Eli Lilly and Teva prepare for court battle over migraine med rivalry
It looks like Eli Lilly and Teva Pharmaceuticals are going to trial.
A federal appeals court on Monday refused to invalidate three of Teva’s patents …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
